Massachusetts Financial Services’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-26,878
Closed -$198K 846
2023
Q2
$198K Sell
26,878
-634
-2% -$4.66K ﹤0.01% 812
2023
Q1
$285K Sell
27,512
-777
-3% -$8.05K ﹤0.01% 821
2022
Q4
$334K Buy
28,289
+598
+2% +$7.06K ﹤0.01% 827
2022
Q3
$581K Sell
27,691
-252
-0.9% -$5.29K ﹤0.01% 807
2022
Q2
$867K Buy
27,943
+140
+0.5% +$4.34K ﹤0.01% 785
2022
Q1
$1.14M Buy
27,803
+285
+1% +$11.7K ﹤0.01% 790
2021
Q4
$1.2M Sell
27,518
-558
-2% -$24.3K ﹤0.01% 809
2021
Q3
$1.41M Sell
28,076
-369
-1% -$18.5K ﹤0.01% 809
2021
Q2
$1.79M Buy
28,445
+243
+0.9% +$15.3K ﹤0.01% 792
2021
Q1
$2.62M Sell
28,202
-3,347
-11% -$311K ﹤0.01% 735
2020
Q4
$2.83M Buy
31,549
+6,796
+27% +$609K ﹤0.01% 703
2020
Q3
$2.56M Buy
24,753
+837
+3% +$86.5K ﹤0.01% 695
2020
Q2
$1.89M Sell
23,916
-612
-2% -$48.4K ﹤0.01% 691
2020
Q1
$1.42M Buy
+24,528
New +$1.42M ﹤0.01% 712
2018
Q4
Sell
-31,970
Closed -$2.11M 861
2018
Q3
$2.11M Sell
31,970
-74
-0.2% -$4.87K ﹤0.01% 716
2018
Q2
$1.62M Buy
32,044
+4,388
+16% +$222K ﹤0.01% 730
2018
Q1
$1.46M Buy
27,656
+517
+2% +$27.2K ﹤0.01% 727
2017
Q4
$1.26M Buy
27,139
+4,432
+20% +$206K ﹤0.01% 732
2017
Q3
$918K Buy
+22,707
New +$918K ﹤0.01% 757
2014
Q3
Sell
-29,945
Closed -$673K 882
2014
Q2
$673K Sell
29,945
-15,095
-34% -$339K ﹤0.01% 826
2014
Q1
$1.14M Sell
45,040
-3,040
-6% -$76.8K ﹤0.01% 743
2013
Q4
$1.11M Sell
48,080
-3,590
-7% -$82.5K ﹤0.01% 716
2013
Q3
$984K Sell
51,670
-1,890
-4% -$36K ﹤0.01% 718
2013
Q2
$772K Buy
+53,560
New +$772K ﹤0.01% 737